background


Product Information:

Casirivimab

Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus, which causes COVID-19. Casirivimab is ineffective against COVID-19 variants. Casirivimab can be used in combination with Imdevimab (EX-A15457), which alters the lung response of K18-hACE2 mice to the SARS-CoV-2 δ variant, effectively reducing viral load and improving symptoms.

Cat. No.: EX-A15458    Purity: >95%
Chemical
Chemical structure of Casirivimab


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
25mg2250in-stock
50mgget quotein-stock
100mgget quotein-stock
500mgget quotein-stock
1gget quotein-stock


SynonymsREGN10933
CAS No.2415933-42-3
Purity>95%
ColorColorless to light yellow
StateLiquid
Shelf Life>3 years if stored properly
StorageStore at -80℃ for 2 years. Aliquots should be stored at the same temperature after first use to avoid multiple freeze-thaws.
ShippingShipping with dry ice.
 
 
Reference:  

[1]. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Casirivimab. 2022 May 15.

[2]. Lee Tatham, et al. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case. Microbiol Spectr. 2024 Aug 6;12(8):e0391623.

CoACoA of Casirivimab

KEYWORDS: buy Casirivimab | Casirivimab supplier | purchase | cost | manufacturer | order | distributor | buy 2415933-42-3 | 2415933-42-3 supplier